Episodes (Page 13)
✨
EFPIA protests US tariffs on innovative drugs.
✨
GSK announces US investment during Trump's UK visit.
Regeneron CEO
✨
GSK plans US investments during UK visit.
Regeneron CEO
✨
ICROM advances HPAPI development and crystallization.
Pierfrancesco Morosini
Pierric Marchand
✨
Novo Nordisk announces 9,000 layoffs.
✨
Novo Nordisk cuts 9,000 jobs globally.
✨
Optimizing biotech-CRO partnerships for funding and trials.
Claire Riches
Matt Simmons
✨
US FDA plans crackdown on direct-to-consumer advertising.
✨
Community-based trials are reshaping clinical research.
✨
Children's Tumor Foundation revives shelved pharmaceutical assets.
✨
US MASH market dynamics post-Wegovy approval.
✨
Sustainability is now a consumer expectation.
Rhea Patten
✨
US FDA removes vaccine expert Paul Offit from advisory committee.
Paul Offit
✨
China releases preliminary list of commercially insured innovative drugs.
✨
Lilly's orforglipron shows promise in diabetic obesity.
OneSource CEO
✨
Korean biotech firms seek alternative funding as VCs become cautious.
✨
Biotech sponsors must make earlier, smarter global trial decisions.
Renita Hite
Scott Schliebner
✨
FDA changes COVID-19 vaccine labeling and EUAs, impacting access.
✨
China's NHSA releases a preliminary list for innovative drug access.
✨
Consumers prioritize brands they 'vibe' with over cost.
Rhea Patten